Modified Ligand Helps Activate Cancer-Fighting T Cells

News   Apr 03, 2018 | Original story from the University of Connecticut

 
Modified Ligand Helps Activate Cancer-Fighting T Cells

This is an illustration showing interactions between components of the AH10-7 compound (yellow), an immune system antigen-presenting cell (gray), and an invariant natural killer T cell (green and blue) that spark activation of iNKT cells in 'humanized' mice. Credit: Jose Gascon/UConn

 
 
 

RELATED ARTICLES

First Detailed Structure of Telomerase Revealed

News

Over 30 years after its discovery, the detailed molecular structure of the longevity protein telomerase has been revealed, which may have implications for cancer treatment and bone marrow transplants.

READ MORE

“Lymphoma Micro-reactor” Targets Chemo-Resistant Lymphoma

News

Researchers have developed a “lymphoma micro-reactor” device that exposes human lymphomas to fluid flow similar to that in the lymphatics and parts of the lymph node.

READ MORE

Researcher Patents Potential Vaccine Candidate for Syphilis

News

University of Victoria microbiologist Caroline Cameron and colleagues have received a patent for a potential vaccine candidate against syphilis.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE